Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (Q34580726)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial |
scientific article |
Statements
1 reference
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (English)
1 reference
Cosette M Wheeler
1 reference
Jorma Paavonen
1 reference
F Xavier Bosch
2 references
S Rachel Skinner
2 references
Wim Quint
1 reference
David Jenkins
1 reference
Paulo Naud
1 reference
Song-Nan Chow
1 reference
Henry C Kitchener
1 reference
Xavier Castellsague
1 reference
Newton S de Carvalho
1 reference
Diane M Harper
1 reference
James A Hedrick
1 reference
Unnop Jaisamrarn
1 reference
Genara Am Limson
1 reference
Marc Dionne
1 reference
Bart Spiessens
1 reference
Pascal Peeters
1 reference
Susan L Wieting
1 reference
Matti O Lehtinen
1 reference
Gary Dubin
1 reference
HPV PATRICIA study group
1 reference
Identifiers
1 reference